Preparation and properties of bovine factor VIII (antihemophilic factor).
about
JNK-ATF-2 inhibits thrombomodulin (TM) expression by recruiting histone deacetylase4 (HDAC4) and forming a transcriptional repression complex in the TM promoterIdentification of the predominant glycosaminoglycan-attachment site in soluble recombinant human thrombomodulin: potential regulation of functionality by glycosyltransferase competition for serine474Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboonInactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in miceDeficiency of protein C in congenital thrombotic diseaseThe nucleotide sequence of the gene for human protein CThe structure and evolution of a 461 amino acid human protein C precursor and its messenger RNA, based upon the DNA sequence of cloned human liver cDNAsDeficiency of protein C inhibitor in combined factor V/VIII deficiency diseaseEstimation of the distance between the divalent cation binding site of des-1-41-light chain-activated bovine plasma protein C and a nitroxide spin label attached to the active-site serine residueLipopolysaccharide-induced decreased protein S expression in liver cells is mediated by MEK/ERK signaling and NFkappaB activation: involvement of membrane-bound CD14 and toll-like receptor-4Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein CCharacterization of a cDNA coding for human protein CMolecular cloning and sequence analysis of the 5'-flanking region of the Sprague-Dawley rat thrombomodulin gene.Surface-mediated control of blood coagulation: the role of binding site densities and platelet depositionAcute inflammation is exacerbated in mice genetically predisposed to a severe protein C deficiency.Biology of tissue factor pathway inhibitor.Mice with a severe deficiency in protein C display prothrombotic and proinflammatory phenotypes and compromised maternal reproductive capabilities.Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactorAntithrombotic effects of thrombin-induced activation of endogenous protein C in primates.Carboxypeptidase U at the interface between coagulation and fibrinolysis.The molecular basis of factor V and VIII procofactor activationBlood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation.Human thrombomodulin is not an efficient inhibitor of the procoagulant activity of thrombin.Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.Abnormal factor VIII coagulant antigen in patients with renal dysfunction and in those with disseminated intravascular coagulation.Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.Biosynthesis of coagulation Factor V by a human hepatocellular carcinoma cell line.Coagulation factor Va binds to human umbilical vein endothelial cells and accelerates protein C activationDetection of protein C activation in humansA protein C deficiency exacerbates inflammatory and hypotensive responses in mice during polymicrobial sepsis in a cecal ligation and puncture modelAnalysis of factor VIII coagulant antigen in normal, thrombin-treated, and hemophilic plasmaA brief historical review of the waterfall/cascade of blood coagulation.Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses.Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma.The Importance of Exosite Interactions for Substrate Cleavage by Human Thrombin.The characterization of mice with a targeted combined deficiency of protein c and factor XI.Inhibition by human thrombomodulin of factor Xa-mediated cleavage of prothrombinEnhancement of rabbit protein S anticoagulant cofactor activity in vivo by modulation of the protein S C4B binding protein interaction.Activation of coagulation releases endothelial cell mitogensInteractions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C.
P2860
Q24297941-D943D4C6-218D-43CD-B8A0-498DC7B9A669Q24528162-3FFDBBFE-0BBD-4E40-B29F-2F2359208480Q24563760-B9E51148-9AAB-4D9E-8722-844E022ABFBBQ24564490-2D56E5F6-0B2B-43BB-BC43-A2B7D07CF81DQ24600822-7B1E4558-B9EE-454B-ADC7-A8345AD492EEQ24613144-371E7CA3-F21B-4542-832E-9430E2279473Q24626095-735DF30F-437E-469F-86B3-BEE6C48920F2Q28263702-EA49A25C-2FD0-460B-A90C-E46907919783Q28359840-5EE779A0-3C65-45AB-8106-50F5122A68DFQ28576699-0C7AACAA-C5F9-4469-9F21-CF2FEB30E3AFQ28631087-BDECBCCD-A809-4B6B-9D40-481B21C2F025Q28646338-4DD5DA2F-C5C5-44EA-8068-AB8E70C29AB4Q30814387-6035175D-142A-4C10-BBEE-D74214210A5AQ33336176-EF964A44-0E55-46C4-AA8D-3C2FB1D81EE1Q33373012-7C2452A2-AFAD-46BE-B0A9-D6DC28D510B9Q33585249-37FA96ED-904F-4F72-ADA6-AF6617D335F1Q33774895-1F5866A8-D9A4-4D0C-8E33-D8DB834C4C2AQ33822980-F4AF342E-F7A6-4ED0-986F-0F2059833D2AQ33905952-3DA6D118-93C2-453C-96ED-5F4361B40227Q34211617-0D1EC82A-DBBF-46E2-B8AB-64FEE0D151ECQ34358555-A89D4498-FC2A-4560-BB27-EC94122B9C5DQ34404185-65842123-60D1-4B73-96F3-E9FC3754CA8CQ34537279-A600F302-0AB3-4652-824D-57E8BF90DD6CQ34550218-87C36A46-3D26-4E67-8B62-C75A648CD129Q34558684-23941BB0-0F5A-40B4-881B-9C45D438D026Q34601867-61BB70AD-41C8-4227-87FA-601A53098189Q34604957-83E17A1C-E0E5-4F68-B201-7BBC7B899A26Q34612041-DF54D630-7A4C-45C1-9DF7-BB9CD8DB6720Q34621922-C5420CEE-80CF-43E4-838B-1A3FB474CC7EQ35103205-0B458475-1182-460A-AF2F-77190C4A5CC7Q35467075-E008053F-3377-428E-B611-FB64B6D0E1E4Q35564946-6CAEC39E-EED4-48F0-BD3E-9681AAA4C9F6Q35582723-1AB468BF-67B5-4072-9CBD-B3ABBDFE320FQ35603064-0DB61326-9971-445A-AABF-37BD146BE4D8Q35674094-2A0A883E-B808-4802-8B29-2E8CCB56BCA5Q35746247-A95B69EF-A7FC-4101-B694-6D51CF206081Q35807376-DD1ACF0D-8E10-496B-9B86-0E93F4D96C15Q35817479-E4A30DEF-F8D3-45FA-A269-001BA3FDA36CQ36213145-F69571C2-9118-4C02-AC2D-E94355D29152Q36278184-22517BBD-D54C-45AB-82AC-C9B68FFFDD45
P2860
Preparation and properties of bovine factor VIII (antihemophilic factor).
description
1980 nî lūn-bûn
@nan
1980 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Preparation and properties of bovine factor VIII (antihemophilic factor).
@ast
Preparation and properties of bovine factor VIII (antihemophilic factor).
@en
Preparation and properties of bovine factor VIII
@nl
type
label
Preparation and properties of bovine factor VIII (antihemophilic factor).
@ast
Preparation and properties of bovine factor VIII (antihemophilic factor).
@en
Preparation and properties of bovine factor VIII
@nl
prefLabel
Preparation and properties of bovine factor VIII (antihemophilic factor).
@ast
Preparation and properties of bovine factor VIII (antihemophilic factor).
@en
Preparation and properties of bovine factor VIII
@nl
P356
P1433
P1476
Preparation and properties of bovine factor VIII (antihemophilic factor).
@en
P2093
P304
P356
10.1021/BI00544A001
P407
P577
1980-02-01T00:00:00Z